Jin-Long Chen's Net Worth
$11.5 Million
Who is Jin-Long Chen?
Jin-Long Chen has an estimated net worth of $11.5 Million. This is based on reported shares across multiple companies, which include NGM BIOPHARMACEUTICALS INC, and Tenaya Therapeutics, Inc..
SEC CIK
Jin-Long Chen's CIK is 0001642996
Past Insider Trading and Trends
2020 was Jin-Long Chen's most active year for acquiring shares with 6 total transactions. Jin-Long Chen's most active month to acquire stocks was the month of December. 2021 was Jin-Long Chen's most active year for disposing of shares, totalling 24 transactions. Jin-Long Chen's most active month to dispose stocks was the month of December. 2023 saw Jin-Long Chen paying a total of $122,518.08 for 545,614 shares, this is the most they've acquired in one year. In 2021 Jin-Long Chen cashed out on 563,888 shares for a total of $6,665,794.62, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
NGM BIOPHARMACEUTICALS INC (NGM) No price found
Chief Scientific Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +7.04% | 64K |
—
|
—
| 972.89K |
Mar 2
| |||
Form 4
|
—
|
0
|
$3.30 | -$315,790.35 | 908.89K |
Jan 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 3
| |||
Form 4
| +4.54% | 39.44K |
$9.93 | -$452,150.64 | 908.89K |
Scheduled
|
Dec 6 - Dec 7
| ||
Form 4
| -3.34% | -30.00K |
$19.73 | -$591,750.00 | 869.45K |
Scheduled
|
Nov 15
| ||
Form 4
| -3.23% | -30.00K |
$20.27 | -$608,250.00 | 899.45K |
Scheduled
|
Oct 11 - Oct 12
| ||
Form 4
| -3.13% | -30.00K |
$25.84 | -$775,305.93 | 929.45K |
Scheduled
|
Sep 13 - Sep 14
| ||
Form 4
| -3.03% | -30.00K |
$23.81 | -$714,222.39 | 959.45K |
Scheduled
|
Aug 9 - Aug 10
| ||
Form 4
| +7.55% | 69.44K |
$1.44 | $99,999.36 | 989.45K |
Jun 3
| |||
Form 4
| -2.65% | -25.00K |
$27.62 | -$690,500.00 | 920K |
Scheduled
|
May 3
| ||
Form 4
| -2.58% | -25.00K |
$24.65 | -$616,250.00 | 945K |
Scheduled
|
Apr 12
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 17
| |||
Form 4
| -2.51% | -25.00K |
$26.66 | -$666,500.00 | 970K |
Scheduled
|
Mar 1
| ||
Form 4
| -2.45% | -25.00K |
$28.75 | -$718,750.00 | 1M |
Scheduled
|
Feb 16
| ||
Form 4
| +13.97% | 125K |
$14.94 | -$642,116.30 | 1.02M |
Scheduled
|
Jan 4 - Jan 5
| ||
Form 4
| -2.72% | -25.00K |
$28.01 | -$700,275.90 | 895K |
Scheduled
|
Dec 14
| ||
Form 4
| -2.65% | -25.00K |
$17.70 | -$442,500.00 | 920K |
Scheduled
|
Nov 2
| ||
Form 4
| -2.58% | -25.00K |
$17.02 | -$425,500.00 | 945K |
Scheduled
|
Oct 12
| ||
Form 4
| -2.51% | -25.00K |
$17.83 | -$445,829.10 | 970K |
Scheduled
|
Sep 1
| ||
Form 4
| -2.45% | -25.00K |
$19.02 | -$475,500.00 | 1M |
Scheduled
|
Aug 10
| ||
Form 4
| -2.39% | -25.00K |
$18.91 | -$472,727.83 | 1.02M |
Scheduled
|
Jul 1
| ||
Form 4
| -2.34% | -25.00K |
$21.65 | -$541,166.00 | 1.05M |
Scheduled
|
Jun 15
| ||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 4
| |||
Form 4
| +7.20% | 71.75K |
$9.47 | -$805,360.94 | 1.07M |
Jan 7 - Jan 9
| |||
Form 4
| +7.76% | 71.75K |
$6.90 | -$544,370.97 | 1M |
Oct 31 - Nov 4
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Tenaya Therapeutics, Inc. (TNYA) Snapshot price: $2.35
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||